Data layers Raw facts Calculated Model prediction AI interpretation

Allotment Overview Calculated

Total Subscription Fees vs Public Offering Raise Amount

Subscription Tier Analysis Model prediction

Expected Lots Allotted by Subscription Tier

Pool A applications , Pool B applications . Expected lots allotted = "Approximate percentage of total shares applied for" as stated in the allotment announcement × shares applied ÷ lot size, taken directly from the announcement.

Capital Efficiency by Subscription Tier

Capital efficiency = Expected shares allotted ÷ shares applied × 100, i.e. the original "Approximate percentage of total shares applied for" value from the allotment announcement. The fewer shares applied for, the higher the capital efficiency.

Applicant Distribution by Subscription Tier

The vertical axis uses a logarithmic scale to better observe distribution differences across tiers of varying magnitudes. All four charts share the same x-axis; hover tooltips are synchronized.

Subscription Fee ÷ Allotted Market Value by Tier

Allotted market value = valid applicants × shares applied × (percentage applied for ÷ 100) × offer price; total handling fees = valid applicants × HKD 100; ratio = total fees ÷ allotted market value × 100%. Lower tiers have disproportionately high ratios due to very small allotments; ratios stabilize at higher tiers.

Allotment Results Subscription Tier List

Loading...

International Offering Raw facts

—
International oversubscription
—
Placee count
3
Cornerstone investors
—
Anchor investors

Cornerstone investors

Name Shares allotted % of global offering % of post-IPO shares Lock-up
安科生物(香港)有限公司 4,245,600 2.75% 1.30% 6 months
Derivatives China Alpha Fund SPC(为及代表Derivatives China Fundamental Fund SP行事) 1,895,300 1.23% 0.58% 6 months
国泰君安证券投资(香港)有限公司(有关中和场外掉期) 1,463,200 3.86% 0.45% 6 months

International concentration

Rank % of international placing % of global offering
前1名 — —
AI AI Analysis AI interpretation deepseek-v4-pro · AI-generated
!
The following content is generated by an AI model based on historical IPO data. It does NOT constitute investment advice, solicitation, or recommendation. Past subscription patterns and post-listing performance do not guarantee future results. Data may contain inaccuracies — always verify against official HKEX filings and prospectuses before making any investment decision.

Market Sentiment

The retail tranche saw an overwhelming 3,526.34x oversubscription, signaling extreme investor enthusiasm for this 18A biotech listing. With a hit rate of just 13.41% and reallocation triggered, the overall subscription was heavily congested, reflecting strong demand despite the high risk profile of pre-revenue biotech firms. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Tier Analysis

A notable tier anomaly: A-tail applicants needed 100,000 lots for an expected allocation of just 1 lot, while B-head applicants required double that (200,000 lots) for the same 1-lot expected return. This creates high capital inefficiency at both tiers, with B-head incurring significantly higher margin interest costs for identical share allocation. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice. Broker fee structures vary; actual costs may differ.)

Demographics

Demographic data for this IPO is not available in the source filings — mainland participation rate, gender split, and regional concentration are all reported as zero or null. Without such breakdown, it’s impossible to comment on the investor profile, though high oversubscription often correlates with strong mainland interest in HK biotech offerings. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice. Data may contain errors or omissions from source documents — verify against official HKEX filings.)

About this page

This page shows allotment analysis for Bao Pharma-B (02659): one-lot hit rate, Pool A/B allotment distribution, oversubscription multiple, and grey-market and first-day performance. Data is parsed from the HKEX allotment results announcement. How allotment rates and clawback work is explained in How Hong Kong IPO Allotment Rates Work.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect